Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-15

Clinical Trial Update: A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics [Phase 3]

View source ↗

Summary

Clinical trial update noting the completion of a Phase 3 study of GW685698X for perennial allergic rhinitis in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED